Clinical trial Recruiting at 64 sites Interventional Ages 18 and up

New pacemaker technology for treating high blood pressure

Official title: BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

Run by Orchestra BioMed, Inc · NCT06059638 · Data updated 2026-11-12

This study is testing a new feature in a Medtronic pacemaker to see if it can help people with high blood pressure feel better while they keep taking their usual medications.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment316 (estimated)
SponsorOrchestra BioMed, Inc
Industry-sponsored
Locations131 sites (Scottsdale, Arizona and 130 other locations)
StatusRecruiting
StartedDecember 27, 2023
Main results expectedDecember 2026
Study endsAugust 2029
Registry record updatedOctober 2, 2026
Trial IDNCT06059638 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with uncontrolled hypertension who are indicated for a dual-chamber pacemaker and are on a stable antihypertensive regimen.

Probably not a fit

Patients with severe heart failure, recent cardiovascular events, or certain heart valve conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm integrated into a Medtronic Astra/Azure dual-chamber pacemaker. The study consists of three phases: a screening phase, a double-blind randomized phase lasting one year, and an unblinded phase extending over two years. Participants with uncontrolled hypertension who are scheduled for or already have a Medtronic pacemaker will be randomized to receive either active AVIM therapy or a deactivated version while continuing their antihypertensive medications.

Why it matters

Potential benefit: If successful, this approach could significantly improve blood pressure control in patients with hypertension.

How similar studies have gone: Other studies have shown promise with device-based therapies for hypertension, but this specific approach is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patient has or is indicated for a dual-chamber pacemaker. Visit 1 can be performed within 30 days prior to a planned implant of a Medtronic Astra/Azure dual-chamber pacemaker system or at any time thereafter
2. On a stable antihypertension treatment regimen with at least 1 class of antihypertensive drug
3. Office SBP ≥135 mmHg and \<180 mmHg
4. Average 24-Hour aSBP ≥130 mmHg and \<170 mmHg

Exclusion Criteria:

1. LVEF \<50%
2. NYHA Class III-IV
3. History of cerebrovascular accident (CVA) or transient ischemic attack (TIA) within 6 months
4. Myocardial infarction (MI) within 3 months
5. Prior percutaneous or surgical coronary, carotid, or endovascular intervention within 3 months
6. Permanent atrial fibrillation
7. Mitral valve regurgitation greater than or equal to grade 3
8. Aortic stenosis with a valve area less than 1.5 cm2
9. Has an active or prior device-based anti-hypertensive treatment (e.g., renal denervation procedure, baroreflex activation therapy)
10. Has an existing active cardiac device or neurostimulator other than the recent Astra/Azure pacemaker implant

Where it's running

  • Adventist Health Glendale
    Glendale, California, United States
    Recruiting
  • Sutter Valley Hospitals
    San Francisco, California, United States
    Recruiting
  • UCHealth Medical Center of the Rockies
    Loveland, Colorado, United States
    Recruiting
  • University of Chicago
    Chicago, Illinois, United States
    Recruiting
  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting
  • Cardiovascular Research Institute of Kansas
    Wichita, Kansas, United States
    Recruiting
Show 44 more locations
  • The Johns Hopkins University
    Baltimore, Maryland, United States
    Recruiting
  • St. Elizabeth's Medical Center
    Boston, Massachusetts, United States
    Recruiting
  • Minneapolis Heart Institute
    Minneapolis, Minnesota, United States
    Recruiting
  • The Cooper Health System
    Camden, New Jersey, United States
    Recruiting
  • Virtua Medical Group, P.A.
    Marlton, New Jersey, United States
    Recruiting
  • Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting
  • HCA Asheville Cardiology Associates
    Asheville, North Carolina, United States
    Recruiting
  • South Oklahoma Heart Research
    Oklahoma City, Oklahoma, United States
    Recruiting
  • Medical University of South Carolina
    Charleston, South Carolina, United States
    Recruiting
  • Baylor Scott & White Research Institute
    Dallas, Texas, United States
    Recruiting
  • Lyell McEwin Hospital
    Elizabeth Vale, South Australia, Australia
    Recruiting
  • Middelheim Ziekenhuis
    Antwerp, Belgium
    Recruiting
  • Universite Libre de Bruxelles-Erasme Hospital
    Brussels, Belgium
    Recruiting
  • UZ Leuven
    Leuven, Belgium
    Recruiting
  • Nanjing Drum Tower Hospital
    Nanjing, Jiangsu, China
    Recruiting
  • Jiangsu Province Hospital
    Nanjing, China
    Recruiting
  • Fakultní nemocnice Královské Vinohrady (FNKV)
    Prague, Czechia
    Recruiting
  • Institute for Clinical and Experimental Medicine (IKEM)
    Prague, Czechia
    Recruiting
  • Na Homolce Hospital
    Prague, Czechia
    Recruiting
  • CHU Grenoble
    Grenoble, France
    Recruiting
  • Hospices Civils de Lyon (HCL)
    Lyon, France
    Recruiting
  • CHU de Nantes
    Nantes, France
    Recruiting
  • AP-HP Hôpital Pitié Salpêtrière
    Paris, France
    Recruiting
  • CHRU Tours
    Tours, France
    Recruiting
  • Universitätsmedizin Berlin, Deutsches Herzzentrum der Charité (DHZC)
    Berlin, Germany
    Recruiting
  • Cardioangiologisches Centrum Bethanien (CCB) am AGAPLESION Markus Krankenhaus
    Frankfurt, Germany
    Recruiting
  • Herzzentrum Leipzig
    Leipzig, Germany
    Recruiting
  • University Hospital Luebeck
    Lübeck, Germany
    Recruiting
  • University Medical Centre Mannheim
    Mannheim, Germany
    Recruiting
  • Saarland University Hospital
    Saarbrücken, Germany
    Recruiting
  • Semmelweis University
    Budapest, Hungary
    Recruiting
  • University of Debrecen
    Debrecen, Hungary
    Recruiting
  • University of Szeged
    Szeged, Hungary
    Recruiting
  • Campus Bio-Medico University Hospital
    Rome, Italy
    Recruiting
  • Azienda Ospedaliera Universitaria Integrata Verona
    Verona, Italy
    Recruiting
  • IRCCS Sacro Cuore Don Calabria
    Verona, Italy
    Recruiting
  • Amsterdam University Medical Centre
    Amsterdam, Netherlands
    Recruiting
  • Maastricht UMC+
    Maastricht, Netherlands
    Recruiting
  • Isala Klinieken
    Zwolle, Netherlands
    Recruiting
  • ChristChurch Hospital
    Christchurch, Canterbury, New Zealand
    Recruiting
  • Górnośląskie Centrum Medyczne im prof Leszka Gieca Śląskiego Uniwersytetu Medycznego w Katowicach
    Katowice, Poland
    Recruiting
  • Jagiellonian University Hospital
    Krakow, Poland
    Recruiting
  • Centralny Szpital Kliniczny Uniwersytetu Medycznego w Łodzi
    Lodz, Poland
    Recruiting
  • Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego
    Lublin, Poland
    Recruiting

+81 more sites. See ClinicalTrials.gov for the full list.

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.